| Chaniqua Dominique Smith, | |
|
956 Molly Barr Rd Apt 2, Oxford, MS 38655 | |
| (166) 280-1295 | |
| Not Available |
| Full Name | Chaniqua Dominique Smith |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 956 Molly Barr Rd Apt 2, Oxford, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164104543 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 906158 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chaniqua Dominique Smith, 956 Molly Barr Rd Apt 2, Oxford, MS 38655-2164 Ph: (662) 801-2950 | Chaniqua Dominique Smith, 956 Molly Barr Rd Apt 2, Oxford, MS 38655 Ph: (166) 280-1295 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced the dosing of the first patient in a Phase I/II clinical trial of the doxorubicin conjugate of milatuzumab for the treatment of patients with relapsed multiple myeloma.
Unilife Corporation wishes to advise that its Form S-1 Resale Registration Statement has now been declared effective by the United States Securities and Exchange Commission ("SEC"). As previously advised, the Registration Statement simply removes restrictions which apply under US federal securities laws to the sale of shares underlying certain options previously issued by the Company.
Silence Therapeutics plc today announced that the company and Dainippon Sumitomo Pharma Co., Ltd. have agreed to an expansion of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in August 2009, the companies are leveraging Silence's proprietary siRNA molecules and multiple lipid delivery and targeting technologies to demonstrate functional delivery of RNA interference (RNAi) therapeutics to specific disease targets in the body.
Increasingly, biologists are turning to computational modeling to make sense of complex systems. In neuroscience, researchers are adapting the kinds of algorithms used to forecast the weather or filter spam from your email to seek insight into how the brain's neural networks process information.
Aetna today announced that it has entered into an agreement with Genworth Financial, Inc. to acquire Genworth's Medicare Supplement business and related blocks of in-force business. Genworth is a leading provider of Medicare Supplement coverage. The business has more than 145,000 Medicare Supplement members.
› Verified 6 days ago
Mrs. Rachel Jamison Sledge, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1487 Belk Blvd, Oxford, MS 38655 Phone: 662-234-1090 Fax: 662-234-0432 | |
Kathryn B Elliott, WHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 551 Azalea Dr, Oxford, MS 38655 Phone: 662-234-0332 Fax: 662-234-2891 | |
Katherine Waters Shields, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Baptist Memorial Cir Ste 120, Oxford, MS 38655 Phone: 662-244-2288 Fax: 662-636-2285 | |
Kirsten A Cox, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2580 Jackson Ave W Ste 44, Oxford, MS 38655 Phone: 662-234-9112 Fax: 662-234-9058 | |
Michelle Cullen, F.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1109 N Lamar Blvd, Suite 1, Oxford, MS 38655 Phone: 662-238-7860 Fax: 662-238-7871 | |
Jene' White Smith, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1397 Belk Blvd, Oxford, MS 38655 Phone: 662-236-4675 Fax: 662-281-0819 | |
Tammy L. Pelegrin, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 504 Azalea Dr, Ste A, Oxford, MS 38655 Phone: 662-236-7738 Fax: 662-236-9642 |